Longitudinal change in neurocognitive functioning in children and adolescents at clinical high risk for psychosis: a systematic review.

Clinical high risk of psychosis (CHR-P) population has become an attractive area of interest in preventing transitions to psychosis. The consequences of developing a psychotic disorder may be worse in cases of early onset. Thus, childhood and adolescence represent a critical developmental window, wh...

Descripción completa

Detalles Bibliográficos
Publicado en:European Child & Adolescent Psychiatry Vol. 33; no. 10; pp. 3377 - 3388
Autores principales: Pedruzo, Borja, Aymerich, Claudia, Pacho, Malein, Herrero, Jon, Laborda, María, Bordenave, Marta, Giuliano, Anthony J., McCutcheon, Robert A., Gutiérrez-Rojas, Luis, McGuire, Philip, Stone, William S., Fusar-Poli, Paolo, González-Torres, Miguel Ángel, Catalan, Ana
Formato: research systematic review tables/charts Journal Article
Publicado: Springer Nature Oct2024
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=180935255&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 180935255
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        10188827
        EJ3
      jtl: European Child & Adolescent Psychiatry
      issn: 10188827
      maglogo: N
    pubinfo:
      dt: Oct2024
      vid: 33
      iid: 10
      pid: 237
      pub: Springer Nature
      place: New York, New York
    artinfo:
      ui:
        180935255
        163778704
        180935255
        180935255
        10.1007/s00787-023-02221-9
        180935255
      ppf: 3377
      ppct: 11
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: P
      tig:
        atl: Longitudinal change in neurocognitive functioning in children and adolescents at clinical high risk for psychosis: a systematic review.
      aug:
        au:
          Pedruzo, Borja
          Aymerich, Claudia
          Pacho, Malein
          Herrero, Jon
          Laborda, María
          Bordenave, Marta
          Giuliano, Anthony J.
          McCutcheon, Robert A.
          Gutiérrez-Rojas, Luis
          McGuire, Philip
          Stone, William S.
          Fusar-Poli, Paolo
          González-Torres, Miguel Ángel
          Catalan, Ana
        affil: Department of Psychiatry, Basurto University Hospital, Bilbao, Spain
      sug:
        subj:
          Cognition Disorders In Infancy and Childhood
          Cognition Disorders In Adolescence
          Psychotic Disorders Risk Factors
          Risk Assessment
          Human
          Systematic Review
          Child
          Adolescence
          Male
          Female
          Executive Function
          Learning
          Attention
          Antipsychotic Agents Therapeutic Use
          Age of Onset
          Child: 6-12 years
          Adolescent: 13-18 years
          Male
          Female
      ab: Clinical high risk of psychosis (CHR-P) population has become an attractive area of interest in preventing transitions to psychosis. The consequences of developing a psychotic disorder may be worse in cases of early onset. Thus, childhood and adolescence represent a critical developmental window, where opportunities to gain social and adaptive abilities depend on the individuals' neurocognitive performance. There have been previous syntheses of the evidence regarding neurocognitive functioning in CHR-P individuals and its longitudinal changes. However, there has been less focus on children and adolescents at CHR-P. A multistep literature search was performed from database inception until July 15th, 2022. PRIMSA/MOOSE compliant systematic review and PROSPERO protocol were used to identify studies reporting on longitudinal changes in neurocognitive functioning in children and adolescents (mean age of sample ≤ 18 years) at CHR-P and matched healthy control (HC) group. A systematic review of identified studies was then undertaken. Three articles were included, resulting in a total sample size of 151 CHR-P patients [mean (SD) age, 16.48 (2.41) years; 32.45% female] and 64 HC individuals [mean (SD) age, 16.79 (2.38) years; 42.18% female]. CHR-P individuals had worse outcomes in verbal learning, sustained attention and executive functioning domains compared to HC. Individuals taking antidepressants had better outcomes in verbal learning in contrast with those taking antipsychotics. In children and adolescents, neurocognition may be already impaired before the psychosis onset, and remains stable during the transition to psychosis. Further study should be performed to obtain more robust evidence.
      pubtype: Academic Journal
      doctype:
        research
        systematic review
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N